Brief: Avenue Therapeutics Provides Regulatory Update On IV Tramadol
08/03/2023 21:06
March 8 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS PROVIDES REGULATORY UPDATE ON IV
TRAMADOL
AND OTHER CORPORATE UPDATES
* AVENUE THERAPEUTICS INC: WILL PARTICIPATE IN A TYPE C
MEETING
WITH FDA ON MARCH 9, 2023
Source text for Eikon: ID:nGNX5DhYZ2
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary